Description

The 1st Middle East Lipid Update Conference 2018 is dedicated to the latest advances and best practices in the management of dyslipidemia and cardiovascular risk for the benefit of patients and the entire population.

The 1st Middle East Lipid Update Conference 2018 covers topics such as:

Major causes of dyslipidemia in the population including diet and inheritance
Raise awareness of Lipids as a major risk factor for cardiovascular disease in the region
The mechanism of action, pharmacokinetics, and efficacy of available FDA approved drugs for the management of lipid disorders
The role of drug therapy in the management of dyslipidemia
The appropriate use of lipid-altering drugs in special populations
The side effects of lipid-altering drugs to encourage their safe use in cardiovascular disease prevention
Effective diet and lifestyle strategies for long-term obesity and dyslipidemia management
Lipid-lowering therapeutic approaches for older adults
Current guidelines on the management and treatment of patients with dyslipidemia
Effective diet and lifestyle ( exercise , weight management) strategies for the management of dyslipidemia and cardiovascular risk
Case studies in lipid management to improve treatment and prevention of cardiovascular disease
Compose a clinical care for reducing risk of CVD in patients with dyslipidemia
The management of dyslipidemia in special populations based on gender, culture, and disease variables
Lipid cases for health professionals seeing patients with complex disorders
Management strategies for the cardiometabolic risk factors of the metabolic syndrome
How obesity and adiposopathy contribute to the metabolic syndrome and diabetes mellitus
Clinical trials of lipid-altering drug therapies used in cardiovascular disease prevention
The side effects of lipid-altering drugs to encourage their safe use in cardiovascular disease prevention
Complex dyslipidemia and dyslipidemia in special populations
Combination therapies for the management of complex lipid disorders and residual risk